Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsCardiovascular / infection

ICU · Cardiovascular / infection

Infective Endocarditis

Also known as Infective endocarditis · IE · Bacterial endocarditis · Duke criteria · Vegetation · Osler nodes · Janeway lesions · HACEK · Culture-negative endocarditis

Infective endocarditis is an infection of the cardiac valves (or the endocardium), diagnosed by the modified Duke criteria: typical positive blood cultures and an echocardiographic vegetation are the major criteria. The commonest ICU organism is Staphylococcus aureus (aggressive, acute); viridans streptococci cause subacute endocarditis (dental); enterococci, the HACEK group, and culture-negative organisms (Coxiella, Bartonella, fungi) are also important. The clinical features: fever, a new or changed murmur, embolic phenomena (stroke, splenic, mesenteric, limb), immunological phenomena (Osler nodes, Roth spots, glomerulonephritis), and vascular phenomena (Janeway lesions). The treatment is 4-6 weeks of IV antibiotics (targeted to the culture). Surgery is indicated for heart failure (the commonest indication), uncontrolled infection, large vegetations with embolism, and perivalvular extension.

high31 referencesUpdated 26 July 202623 min readSource-verified · Oct 2026

Checked against its sources on 14 Oct 2026

Your progress

Saved on this device.

Target exams

CICMFFICMEDIC
On this page
Study tools

Your progress

Saved on this device.

Target exams

CICMFFICMEDIC
The one-line answer

Infective endocarditis is a microbial infection of the endocardial surface — usually a valve — diagnosed by the modified Duke criteria: two major (typical blood cultures from two sites plus an echo vegetation or abscess), or one major plus three minor, or five minor. The commonest ICU organism is Staphylococcus aureus (aggressive, acute, hits normal valves, highest mortality); viridans streptococci cause the subacute dental form; S. gallolyticus means colonoscopy. The treatment is 4 to 6 weeks of IV bactericidal antibiotics targeted to the culture — but heart failure is the commonest reason for surgery, and waiting for the antibiotics to work in uncontrolled heart failure is a fatal error.[1]

Meet the patient

A diabetic man with days of fever and rigors, now breathless. A new pansystolic murmur at the apex, bilateral crackles, and splinter haemorrhages. Three sets of blood cultures grow methicillin-sensitive Staphylococcus aureus. The transthoracic echo shows a mobile mitral vegetation with severe mitral regurgitation. Hours in, he develops a right hemiparesis and dysphasia — a left MCA infarct with a small haemorrhagic transformation.[6][11]

Every decision in his next day hangs on one question the registrar keeps getting wrong: when do you operate? The answer is governed by the heart failure, the vegetation, and the stroke — in that order. Hold that tension and the whole topic slots into place.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References31ShowHide
  1. [1]Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis Eur Heart J, 2023.PMID 37622656
  2. [2]Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J, 2015.PMID 26320109
  3. [3]Iversen K, Ihlemann N, Gill SU, et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis N Engl J Med, 2019.PMID 30152252
  4. [4]Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med, 2012.PMID 22738096
  5. [5]Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality JAMA, 2003.PMID 12697795
  6. [6]Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress JAMA, 2005.PMID 15972563
  7. [7]Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis, 2000.PMID 10770721
  8. [8]Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation, 2005.PMID 15956145
  9. [9]Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study Arch Intern Med, 2009.PMID 19273776
  10. [10]Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, 2007.PMID 17446442
  11. [11]Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis J Am Coll Cardiol, 2001.PMID 11263610
  12. [12]Chirouze C, Alla F, Fowler VG Jr, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study Clin Infect Dis, 2015.PMID 25389255
  13. [13]Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study Eur Heart J, 2019.PMID 31504413
  14. [14]Cahill TJ, Prendergast BD. Infective endocarditis Lancet, 2016.PMID 26341945
  15. [15]Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association Circulation, 2015.PMID 26373316
  16. [16]Starkel S, Goodberlet M, Schuler B, et al. Evaluating the incidence of acute kidney injury and gentamicin synergy dosing for endocarditis. JAC Antimicrob Resist, 2024.PMID 38161960
  17. [17]Wilson WR Antimicrobial therapy of streptococcal endocarditis. J Antimicrob Chemother, 1987.PMID 3316158
  18. [18]Eykyn SJ The treatment of staphylococcal endocarditis. J Antimicrob Chemother, 1987.PMID 3316159
  19. [19]Lee A, Mirrett S, Reller LB, et al. Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol, 2007.PMID 17881544
  20. [20]Naber CK, Erbel R Infective endocarditis with negative blood cultures. Int J Antimicrob Agents, 2007.PMID 17890062
  21. [21]Rybak MJ, Le J, Lodise TP, et al. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis, 2020.PMID 32658968
  22. [22]Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med, 2006.PMID 16914701
  23. [23]Pericas JM, Cervera C, del Rio A, et al. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clin Microbiol Infect, 2014.PMID 25040215
  24. [24]Meena DS, Kumar D, Bohra GK Combination antibiotic therapy in Staphylococcus aureus endocarditis: evidence, controversies, and future directions. Infection, 2026.PMID 42149364
  25. [25]Boleij A, van Gelder MM, Swinkels DW, et al. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis, 2011.PMID 21960713
  26. [26]Pericàs JM, Llopis J, Athan E, et al. Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs. J Am Coll Cardiol, 2021.PMID 33538252
  27. [27]Limeres Posse J, Álvarez Fernández M, Fernández Feijoo J, et al. Intravenous amoxicillin/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial. J Antimicrob Chemother, 2016.PMID 27029851
  28. [28]Mohananey D, Mohadjer A, Pettersson G, et al. Association of Vegetation Size With Embolic Risk in Patients With Infective Endocarditis: A Systematic Review and Meta-analysis. JAMA Intern Med, 2018.PMID 29459947
  29. [29]Yanagawa B, Pettersson GB, Habib G, et al. Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Practical Recommendations for Clinicians. Circulation, 2016.PMID 27777297
  30. [30]Bettencourt S, Ferro JM Acute Ischemic Stroke Treatment in Infective Endocarditis: Systematic Review. J Stroke Cerebrovasc Dis, 2020.PMID 32024600
  31. [31]Wong D, Wong T, Romney M, et al. Comparative effectiveness of beta-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Ann Clin Microbiol Antimicrob, 2016.PMID 27112143
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousICU-Acquired Infection Prevention Bundle — Comprehensiveicu-acquired-infectionNextLactic Acidosis — Type A, B & D, MALA, and Lactate ClearanceRenal / acid-base